FDA defends generic drug label proposal at U.S. House hearing
April 01, 2014 at 18:58 PM EDT
April 1 (Reuters) - The U.S. Food and Drug Administration on Tuesday defended its proposal to require generic drugmakers to update the prescribing information on their products if they become aware of new safety information, a move the industry says will open them to product liability lawsuits and raise drug costs.